No Detail Found!

Outcomes of Hereditary Breast-Ovarian Cancer Syndrome: A single center experience

Author(s)
MANZOOR KHAN Department of Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore.Pakistan
SAMEEN BIN NAEEM Department of Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore.Pakistan
SHAZIA ASIM Department of Pharmacology, Lahore Medical & Dental College, Lahore.Pakistan
MUSSADIQUE ALI JHATTIAL Department of Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore.Pakistan
NEELAM SIDDIQUI Department of Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore.Pakistan
Abstract
Aim: To assess the survival and progression patterns of Hereditary Breast and Ovarian Cancer (HBOC) at our hospital. Methods: We did retrospective cohort study of thirty patients presenting with hereditary breast ovarian and cancer diagnosed and treated at Shaukat Khanum Memorial Cancer Hospital and Research Center (SKMCH&RC), Lahore, Pakistan from 1994 to 2012. Patient's demographics, clinical and histopathology data was obtained from cancer registry department of SKMCH&RC hospital. Chi-square test and independent sample T-test were used to analyze the data to find the association between variables i.e. age, comorbidities, BMI and progression free survival. Result: All patients except two received chemotherapy and surgery as per guidelines. Of the thirty patients, thirteen patients had shown progression free survival (PFS) out of which one patient died whereas progression of disease was observed in seventeen patients of HBOC out of which six patients were expired. Comorbidities and family history of cancer did not show statistically significant results for the mortality (P > 0.05). Metastasis and presence of ascites indicated statistically significant influence on PFS having P value < 0.05. CA-125 at presentation, chemotherapy usage and adjuvant therapy did not show significant impact on PFS (P > 0.05). Conclusion: Seven cases of diagnosed HBOC died. We identified that there were 43.33% cases of diagnosed HOBC who met progression free survival and rest developed the progression. Metastasis and presence of ascites showed significant impact for the progression of disease.
Publication Details
Page(s) 114-115
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 6, Year: 2022

Request the full text from PASTIC

Keywords
Hereditary Breast and Ovarian cancer (HBOC)., BRCA mutation, Progression free survival (PFS)
References
Foulkes WD,Narod SA .1995 .Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing. Clin Invest Med, 18(6) : 473-483.
Rashid MU,Muhammad N,Bajwa S .2016 .Published 2016 Aug 23. BMC Cancer, 16(1) : 673-1180.
Zhu Y,Wu J,Zhang C,Chen C,Xu Y,Huang X,Claes E,Evers-Kiebooms G,Denayer L .2005 .Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure. J Genet Couns, 14(5) : 349-363.
Zorn KK,Tian C,McGuire WP .2017 ."Ascitic Fluid in Ovarian Carcinoma - From Pathophysiology to the Treatment". Cancer, 10(5) : 1028-1035.
. .. , : .
Ahmed N,Stenvers KL,Latifi A,Luwor RB,Bilandzic M .2012 .Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS One, 7(10) : e46858.
Rafehi S,Ramos Valdes Y,Bertrand M,Slack-Davis JK,Atkins KA,Harrer C,Hershey ED,Conaway M.,Long KC,Kauff ND .2011 .Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies. Curr Opin Oncol, 23(5) : 526-530.
. .. doi:10, : .
0

Citations

0

Downloads

90

Views